🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We’re at #CMSC 🧠 Stop by the our booth (703) to learn about all things TSF 🩷🧡💛

Great to see Dr. Eoin Flanagan leading a session about #MOGAD at #CMSC2025 🧠

Descubre por que el Yoga es para todos y puede ayudarte. El yoga no es esa idea que se tiene de una disciplina física. El Yoga es mas que físico, es celular, mental, intelectual y espiritual: te afecta en todo tu ser. us02web.zoom.us/webinar/regist…

Happy 4-year work-versary to my business partner, strategic advisor, best friend and partner in cause, the one and only Michael ☄️ together, we are unstoppable 🩷

#WorldMSDay2025: Testing for myelin oligodendrocyte glycoprotein #MOGAD antibodies: Who, what, where, when, why, and how! Review from Adrian Budhram London Health Sciences Centre Western University Eoin Flanagan Mayo Clinic Neuro ▶️ journals.sagepub.com/doi/full/10.11…

🇮🇹 Buona Festa della Repubblica dal team di TSF Italia! In questa giornata speciale, ribadiamo il nostro impegno in Italia per #NMOSD e #MOGAD: sensibilizzare, informare e supportare chi ne è colpito.

🇩🇪 Lernen Sie Marcel kennen, den neuen Botschafter der TSF in Deutschland! Im Jahr 2016 veränderte sich Marcels Leben grundlegend: Bei ihm wurde eine damals noch namenlose Krankheit diagnostiziert – heute bekannt als #MOGAD.

🏳️‍🌈🏳️‍⚧️ June is pride month but pride is more than a month. We recognize the challenges faced by those navigating both an LGBTQIA+ identity and a rare disease diagnosis, and we’re here to ensure you don’t have to face them alone. Let’s connect, share & uplift each other. 🩷🧡💛

Autoantibodies against myelin oligodendrocyte glycoprotein in a subgroup of patients with psychotic symptoms frontiersin.org/journals/neuro…

A study in Neurology and Therapy by Marco Capobianco and team revealed a major disconnect in how neurologists versus patients perceive disease severity and stability in #NMOSD. Read the summary: sumairafoundation.org/summaries/char…

Don't Miss ECTRIMS Pre-Day! ✅ Insights into rare neuroimmune diseases ✅ In-depth sessions on NMOSD, MOGAD, autoimmune encephalitis & HSV encephalitis + more ✅ Happening in beautiful Barcelona on 23 Sept ✍️ Book your seat now! bit.ly/4gYUuIA #ECTRIMS2025

TSF is inviting #NMOSD, #MOGAD and #AE patients, caregivers and clinicians in and around Chicagoland to join us! Join us on July 26th for our Chicago Patient Day Rare Neuroinflammatory Disorders. Register here: eventbrite.com/e/tsfs-chicago…

Just published 👉 A NEWLY updated, comprehensive meta-analysis of the treatment of anti-NMDAR encephalitis: Analysis, equipoise, and the urgent need for evidence over anecdote 🧠🔥 Why is this paper so important ? 1/

✋ 🛑 We must do better. If available clinical trials are not discussed and offered to patient/loved ones BEFORE immunotherapy is given, then it is NOT informed care. KNOWLEDGE = POWER @ExTINGUISHTrial

We can’t wait to see you all tomorrow at TSF's Washington DC Patient Day for #NMOSD & #MOGAD! Registration begins at 10AM… see you then 😎

Dr. Brenda Banwell shares the process and commitment of developing the international diagnostic criteria of #MOGAD with our live audience at DC Patient Day 🇺🇸

🎥 In this interview, Sumaira Flower 🍉, of The Sumaira Foundation, discussed a newly funded international trial evaluating both approved and off-label therapies for #NMOSD, aiming to help inform future treatment decisions and patient care. #CMSC25 CMSC Watch here:

See you at European Academy of Neurology in Helsinki 🇫🇮 #NMOSD #MOGAD

No matter what #raredisease you have, in the clerb, we all FAM! Thanks for a great Patient Day, DC - we love you 🩷🧡💛 #NMOSD #MOGAD

We’re excited to launch “Side-by-Side,” an educational series that explores the power of shared decision-making (SDM) and aims to educate our audience on how to achieve it. Check out the videos, checklist and other helpful tools here: sumairafoundation.org/side-by-side-y….